Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunopathogenesis of neuromyelitis optica.
Pregnancy and multiple sclerosis.
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
Episode 22 with Dr. Paul Matthews discussing the Optimize project in the UK
Best practice in the use of natalizumab in multiple sclerosis.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
The neuroendocrine axis in patients with multiple sclerosis.
The relevance of animal models in multiple sclerosis research.
Use of fumaric acid esters in psoriasis.
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
Experimental models of spontaneous autoimmune disease in the central nervous system.
American Academy of Neurology: Breakthroughs in Neurology
Cognitive Test Analysis May Determine Reliable MS Change Over Time
Seeing illness in art and medicine: a patient and printmaker collaboration.
National MS Society: Sylvia Lawry Physician Fellowships
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Environmental, modifiable risk factors for multiple sclerosis

Pages